Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma.

about

Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma.

Item

http://www.wikidata.org/entity/Q47168459

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Efficacy of rituximab combined ...... diffuse large B-cell lymphoma.

@en

Efficacy of rituximab combined ...... diffuse large B-cell lymphoma.

@nl

type

Item

label

Efficacy of rituximab combined ...... diffuse large B-cell lymphoma.

@en

Efficacy of rituximab combined ...... diffuse large B-cell lymphoma.

@nl

prefLabel

Efficacy of rituximab combined ...... diffuse large B-cell lymphoma.

@en

Efficacy of rituximab combined ...... diffuse large B-cell lymphoma.

@nl

P1476

Efficacy of rituximab combined ...... diffuse large B-cell lymphoma.

@en

P2093

Li Guo

http://www.w3.org/2001/XMLSchema#string

Min Zeng

http://www.w3.org/2001/XMLSchema#string

Shan Li

http://www.w3.org/2001/XMLSchema#string

Shan-Shan Ding

http://www.w3.org/2001/XMLSchema#string

Shu-Juan Wen

http://www.w3.org/2001/XMLSchema#string

Shun-E Yang

http://www.w3.org/2001/XMLSchema#string

Xiao Liang

http://www.w3.org/2001/XMLSchema#string

Xin Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

My treatment approach to patients with diffuse large B-cell lymphoma.

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.

Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era.

Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography.

Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP.

Multifocal extranodal lymphoma: A case report.

P304

e8494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000008494

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29137041

http://www.w3.org/2001/XMLSchema#string

P932

5690734

http://www.w3.org/2001/XMLSchema#string